IMIST


Drug monitoring and clinical chemistry / (notice n° 30260)

000 -LEADER
fixed length control field 05210cam a2200589Ii 4500
001 - CONTROL NUMBER
control field ocn162578985
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211202111224.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 070806s2004 ne a ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency OPELS
Language of cataloging eng
Transcribing agency OPELS
Modifying agency OPELS
-- OCLCQ
-- OCLCF
Description conventions rda
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780444509727
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0444509720
029 1# - (OCLC)
-- NZ1
-- 12433551
029 1# - (OCLC)
-- DEBBG
-- BV039828704
029 1# - (OCLC)
-- NZ1
-- 15188893
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)162578985
037 ## - SOURCE OF ACQUISITION
Stock number 91395:91392
Source of stock number/acquisition Elsevier Science & Technology
Note http://www.sciencedirect.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.9
Item number .D78 2004eb
072 #7 - SUBJECT CATEGORY CODE
Subject category code RS
Source lcco
072 #7 - SUBJECT CATEGORY CODE
Subject category code QD
Source lcco
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIA
245 00 - TITLE STATEMENT
Title Drug monitoring and clinical chemistry /
Statement of responsibility, etc edited by Georg Hempel.
264 #1 -
-- Amsterdam :
-- Elsevier,
-- 2004.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (340 pages) :
Other physical details illustrations.
336 ## - CONTENT TYPE
Content Type Term text
Content Type Code txt
Source rdacontent
337 ## - MEDIA TYPE
Media Type Term computer
Media Type Code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier Type Term online resource
Carrier Type Code cr
Source rdacarrier
347 ## -
-- data file
-- rda
380 ## -
-- Bibliography
490 1# - SERIES STATEMENT
Series statement Handbook of analytical separations ;
Volume number/sequential designation v. 5
520 ## - SUMMARY, ETC.
Summary, etc This book, the 5th volume in the Handbook of Analytical Separations series, gives an overview about methods to analyse drugs in biological fluids. The most widely used methods to analyse drugs in biological fluids. id est chromatographic methods, CE and immunoassays are described in detail. For important drugs, an overview about the methods available and a comparison of the techniques should be given to enable the reader to choose the right method depending on laboratory equipment, staff, the aim of the investigation et cetera Other general aspects important for conducting therapeutic drug monitoring or pharmacokinetics studies are also covered, id est sample preparation, validation of the analytical methods and pharmacokinetic methods for interpreting the data. Areas where therapeutic drug monitoring is used frequently such as antibiotics, immunosuppressant drugs, antipsychotic and anticancer drugs will be discussed in detail. In addition, the important field of phenotyping and genotyping for therapy optimisation with special focus on real-life applications is also covered. The book contains important information for analyst working on drug analysis in clinical chemistry, hospital pharmacists involved in therapeutic drug monitoring, other pharmacists, chemists or physicians working on pharmacokinetic studies in industry or academia. In contrast to other books in this field, this book provides up-to-date information regarding both methodology and clinical applications. For the applications, only fields are described where therapeutic drug monitoring is used in clinical routine and provides benefit to the patients. 1. Overview of all important field where therapeutic drug monitoring is applied 2. All relevant analytical and computational methods are discussed 3. Written by experts with a lot of practical experience in the field.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Sample preparation for the analysis of drugs in biological fluids (Yoshihiro Saito and others). -- Chromatographic methods for the analysis of drugs in biological fluids (Hassan Y. Aboul-Enein et al). -- Capillary electrophoresis for the determination of drugs in biological fluids (Zakariya K. Shihabi). -- -- Immunoassays for the therapeutic drug monitoring and clinical toxicology(W. Clarke). -- -- Validation of bioanalytical methods (S. Berthier). -- -- Pharmacokinetic methods for the analysis, interpretation and management of TDM data, and for individualising drug dosage regimens optimally -- (R. Jelliffe and others). -- Dose and therapy individualisation in cancer chemotherapy (G. Hempel). -- Rationale and utility of therapeutic drug monitoring for the optimisation of antibiotic therapy(C. Ong, D.P. Nicolau). -- Therapeutic drug monitoring of antiepileptic drugs -- (S.I. Johannessen). -- Therapeutic drug monitoring of antipsychotic and antidepressant drugs (P.B. Mitchell). -- Monitoring immunosuppressant drugs (D.W Holt, A. Johnston). -- Pharmacogenomics: methodologies for genotyping and phenotyping (P. Jannetto and others). -- Applications of genotyping and phenotyping for clinically relevant polymorphisms of drug metabolizing enzymes and drug transporters -- A. Lazar and others).
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
588 ## -
-- Description based on print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug monitoring.
9 (RLIN) 48817
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical chemistry.
9 (RLIN) 48818
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
9 (RLIN) 48819
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 20
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical chemistry.
Source of heading or term fast
-- (OCoLC)fst00864330
9 (RLIN) 48818
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug monitoring.
Source of heading or term fast
-- (OCoLC)fst00898688
9 (RLIN) 48817
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis.
Source of heading or term fast
-- (OCoLC)fst00898769
9 (RLIN) 48819
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hempel, Georg.
9 (RLIN) 26686
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
Title Drug monitoring and clinical chemistry.
Place, publisher, and date of publication Amsterdam : Elsevier, 2004
International Standard Book Number 0444509720
-- 9780444509727
Record control number (OCoLC)54825587
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Handbook of analytical separations ;
Volume number/sequential designation v. 5.
9 (RLIN) 48820
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://www.sciencedirect.com/science/book/9780444509727">http://www.sciencedirect.com/science/book/9780444509727</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Ebook
956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC)
Electronic name Pré 2007
994 ## -
-- 92
-- MAIMI

Pas d'exemplaire disponible.

© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha